1型糖尿病儿童的β-区域周周细胞缩 (β-PPA) 的形态变化:一项纵向研究
Shuchang Zhang1,2, Chenhao Yang3, Qingyu An1,2
1Department of Ophthalmology, Shanghai General Hospital, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai, China.
概括
在患有1型糖尿病的儿童中,轴延长和血清直接胆红素水平预测三年内视觉盘周周状β区域缩 (β-PPA) 的进展. 较高的直接胆红素与较慢的β-PPA生长有关.
科学领域:
- 眼科医生 眼科 眼科
- 糖尿病学 糖尿病学
- 生物化学 生物化学
背景情况:
- 1型糖尿病 (T1D) 的管理需要对眼部并发症进行监测.
- 视盘周边皮囊 β-区域缩 (β-PPA) 是一种在视神经头部观察到的形态变化.
- 了解糖尿病儿童的β-PPA进展对于早期干预至关重要.
研究的目的:
- 追踪三年来T1D儿童β-PPA的形态变化和进展.
- 评估血清生物化学标志物对β-PPA进展的预测值.
主要方法:
- 一项观察性临床队列研究跟踪了24名T1D儿童三年.
- 眼科检查,包括OCT成像,评估β-PPA区域和光盘圆性.
- 记录了血清生化标志物和人口统计数据;回归分析确定了β-PPA变化的预测因素.
主要成果:
- 在三年内,轴长和β-PPA面积显著增加,折射的近视转移.
- 轴延长的增加和更高的基线超视折射与更大的β-PPA增加相关.
- 较高的基线直接胆红素 (DBil) 与较慢的β-PPA生长有关,被确定为负独立预测因子.
结论:
- 血清直接胆红素水平,与轴延长一起,可以帮助识别患有快速β-PPA进展风险的儿童.
- 这一发现可能有助于在儿童T1D患者中对β-PPA的早期风险分层.
- 建议在更大的队列中进一步验证.
相关概念视频
Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32


